Table 1.
Prosthetic cardiac valve or prosthetic material used for cardiac valve repair |
|
Previous infective endocarditis |
|
Cardiac transplantation recipients who develop cardiac valvulopathy |
|
Congenital heart disease |
(i) Unrepaired cyanotic CHD, including palliative shunts and conduits |
(ii) Completely repaired congenital heart defect with prosthetic material or device, whether placed by surgery or by catheter intervention, during the first 6 months after the procedure |
(iii) Repaired CHD with residual defects at the site or adjacent to the site of a prosthetic patch or prosthetic device (which inhibit endothelialization) |